Usp22 is an intracellular regulator of systemic emergency hematopoiesis.
Nikolaus DietleinXi WangJonas MetzOlivier DissonFuwei ShangCeline BeyersdörfferEsther Rodríguez CorreaDaniel B LipkaYvonne Begus-NahrmannRobyn Laura KosinskySteven A JohnsenMarc LecuitThomas HöferHans-Reimer RodewaldPublished in: Science immunology (2022)
Emergency hematopoiesis is a concerted response aimed toward enhanced protection from infection, involving multiple cell types and developmental stages across the immune system. Despite its importance, the underlying molecular regulation remains poorly understood. The deubiquitinase USP22 regulates the levels of monoubiquitinated histone H2B (H2Bub1), which is associated with activation of interferon responses upon viral infection. Here, we show that in the absence of infection or inflammation, mice lacking Usp22 in all hematopoietic cells display profound systemic emergency hematopoiesis, evident by increased hematopoietic stem cell proliferation, myeloid bias, and extramedullary hematopoiesis. Functionally, loss of Usp22 results in elevated phagocytosis by neutrophilic granulocytes and enhanced innate protection against Listeria monocytogenes infection. At the molecular level, we found this state of emergency hematopoiesis associated with transcriptional signatures of myeloid priming, enhanced mitochondrial respiration, and innate and adaptive immunity and inflammation. Augmented expression of many inflammatory genes was linked to elevated locus-specific H2Bub1 levels. Collectively, these results demonstrate the existence of a tunable epigenetic state that promotes systemic emergency hematopoiesis in a cell-autonomous manner to enhance innate protection, identifying potential paths toward immune enhancement.
Keyphrases
- public health
- immune response
- emergency department
- oxidative stress
- healthcare
- cell proliferation
- dendritic cells
- bone marrow
- hematopoietic stem cell
- single cell
- listeria monocytogenes
- gene expression
- emergency medical
- induced apoptosis
- acute myeloid leukemia
- cell therapy
- transcription factor
- poor prognosis
- dna methylation
- genome wide
- cell cycle arrest
- stem cells
- risk assessment
- cell death
- adipose tissue
- signaling pathway
- insulin resistance
- pi k akt
- drug induced
- skeletal muscle
- energy transfer